Reneo Pharmaceuticals Inc.
13F holders, Q4 2025 (December 31)1holders −49
0new positions
0sold out
$2.90avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Reneo Pharmaceuticals Inc. in their 13F filings, down 49 from Q3 2024. 0 opened new positions and 0 sold out. The largest holder was Torren Management, LLC ($1K).
- Company
- Reneo Pharmaceuticals Inc.
- Filed as
- ONKURE THERAPEUTICS INC COM CL A (Q4 2025)
- CUSIP
- 75974E103
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Torren Management, LLC | 0.00% | — | 504 | $1K |
"% of holder's portfolio" is RENEO PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Reneo Pharmaceuticals Inc. the manager owns.